RxDoctor Payments Data

Anastasia Kovalaske, NP

Nurse Practitioner · Bloomington, ILNPI 1790118586

Payments from drug & device makers

$5,282in general payments, 2019–2025

Across 256 payments — averaging $20.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Sumitomo Pharma America, Inc.$933
  • Astellas Pharma US Inc$768
  • Johnson & Johnson$459
  • Merck$377
  • Convatec Inc.$352
  • Pfizer$297
  • plus $2K from 39 others

What the payments were for

  • Food & beverage$4,73990%
  • Education$54310%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$5,282 in reported general payments places this provider in the 95th percentile of 4,869 nurse practitioner providers in Illinois.

See all nurse practitioner providers in Illinois

Medicare billing

Part B allowed, 2024
$236,397
Medicare patients
776
Services billed
41,739

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MyrbetriqMirabegron393$326,724
GemtesaVibegron301$261,578
Mirabegron ErMirabegron44$35,093
Tamsulosin Hcl1,217$19,749
Estradiol194$12,473
Silodosin80$6,266
Solifenacin Succinate85$4,925
Tolterodine Tartrate ErTolterodine Tartrate15$2,654
Finasteride171$2,526
Trimethoprim34$2,412
Potassium Citrate ErPotassium Citrate23$2,368
Testosterone14$2,107
NitrofurantoinNitrofurantoin Macrocrystal44$2,038
Testosterone Cypionate34$1,904
Oxybutynin Chloride ErOxybutynin Chloride36$1,417

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Astellas Pharma US IncMyrbetriq$768$326,724393 claims
Sumitomo Pharma America, Inc.Gemtesa$933$261,578301 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 4,869 nurse practitioner providers in Illinois.

Other nurse practitioner in Bloomington

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →